NCT03052569No Longer Available不适用
Expanded Access to RXDX-105 for the Treatment of Cancers With RET Alterations
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 1
研究概览
简要总结
Expanded access to RXDX-105 will be given to patients with cancers harboring RET alterations who have not received TKIs that target RET alterations, who do not qualify for participation in, or who are otherwise unable to access, an ongoing clinical trial for RXDX-105.
研究设计
- 研究类型
- Expanded Access
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of advanced cancer with RET alterations
- •Unable to participate in an ongoing RXDX-105 clinical trial
- •Willing and able to provide written, signed informed consent
- •Medically suitable for treatment with RXDX-105
排除标准
- •Prior treatment with a TKI that has activity against RET alterations
- •Currently enrolled in an ongoing clinical study with any other investigational agent
研究者
研究点 (1)
Loading locations...
相似试验
Approved For Marketing
不适用
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) ActivationNon Small Cell Lung CancerMedullary Thyroid CancerPapillary Thyroid CancerOther Solid Tumors With Evidence of Activating RET AlterationBreast CancerPancreatic CancerColon CancerNCT03906331Eli Lilly and Company
No Longer Available
不适用
Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET InhibitorCarcinoma, Non-Small-Cell LungThyroid NeoplasmsNCT05225259Eli Lilly and Company
No Longer Available
不适用
Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene FusionsCancers With NTRK, ROS1, or ALK Gene FusionsNCT03066661Hoffmann-La Roche
Approved For Marketing
不适用
Expanded Access to Provide Larotrectinib for the Treatment of Cancers With a NTRK Gene FusionTumors Harboring NTRK FusionNCT03025360Bayer
No Longer Available
不适用
Expanded Access (Compassionate Use) Treatment Protocol RindopepimutRecurrent GBMNCT03068650Celldex Therapeutics